MENU
RXRX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Recursion Pharmaceuticals (RXRX) Ownership - Who owns Recursion Pharmaceuticals?
Recursion Pharmaceuticals Inc is a clinical-stage biotechnology company... Show more
Profile
Industry
N/A
Address
41 S Rio Grande Street
Phone
+1 385 269-0203
Employees
500
Web
https://www.recursion.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
2.26B
P/E Ratio
N/A
Total Cash
594.35M
Projected Growth
N/A
Total Debt
108.49M
Revenue
58.49M
Risk (Beta)
1.16
Dividend Yield
N/A
Total Cash/Share
1.48
Total Debt/Equity
N/A
Revenue/Share
0.21 USD as % of share price
Fundamentals
RXRX
Capitalization
2.26B
P/E Ratio
N/A
Risk (Beta)
1.16
Dividend Yield
N/A
Total Cash
594M
Total Cash/Share
1.48
Total Debt
108M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.21%
Revenue
58.5M
ROE
N/A
Book Value
1.04B
P/B Ratio
2.19
Cash Flow
N/A
Earnings
-1.69
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
4K
Current Ratio
3.81
Current Revenue Per Employee
5638.75
Dividends Per Share - Security
N/A
EBITDA
-426.72M
Float
N/A
Float - Current
N/A
Gross Income Margin
-183.62
Revenue To Assets
-44.11
Shares Held By Institutions
8.04B
Shares Outstanding - Current
402M
Total Liabilities
414M
Total Volume MTD
N/A
Value
N/A
Gain YTD
-19.970
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
41 S Rio Grande Street
Phone
+1 385 269-0203
Employees
500
Web
https://www.recursion.com